BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 9224305)

  • 1. Novel vitiligo susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis.
    Spritz RA; Gowan K; Bennett DC; Fain PR
    Am J Hum Genet; 2004 Jan; 74(1):188-91. PubMed ID: 14691733
    [No Abstract]   [Full Text] [Related]  

  • 2. Loss of chromosome Y in primary tumors.
    Qi M; Pang J; Mitsiades I; Lane AA; Rheinbay E
    Cell; 2023 Jun; ():. PubMed ID: 37385248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin-secreting metanephric adenoma presenting as erythrocytosis.
    Liu A; Kremyanskaya M; Mehrazin R; Si Q; Robinson BD; Cushing MM; Hoffman R; Ginzburg YZ
    Am J Hematol; 2023 Nov; 98(11):1808-1813. PubMed ID: 37528578
    [No Abstract]   [Full Text] [Related]  

  • 4. A case report of renal dysplasia with papillary adenoma.
    Shi Y; Xia C; Zhang P; Kong W; Yang D
    Asian J Surg; 2024 Mar; 47(3):1398. PubMed ID: 38036357
    [No Abstract]   [Full Text] [Related]  

  • 5. Case Report: MRI, CEUS, and CT Imaging Features of Metanephric Adenoma with Histopathological Correlation and Literature Review.
    Gohla G; Bongers MN; Kaufmann S; Kraus MS
    Diagnostics (Basel); 2022 Aug; 12(9):. PubMed ID: 36140473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic atypical renal tumour with metanephric characteristics treated with Sunitinib.
    Mohammad H; Madsen K; Graumann O; Loya AC; Jensen NV; Dahlrot RH
    Urol Case Rep; 2022 Jan; 40():101880. PubMed ID: 34692420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience of diagnosis and management of metanephric adenoma: retrospectively analysis of 10 cases and a literature review.
    Zhang L; Gao X; Li R; Li K; Liu B; Li J; Zhang W; Tang M
    Transl Androl Urol; 2020 Aug; 9(4):1661-1669. PubMed ID: 32944527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal aberrations in renal cell carcinoma: An overview with implications for clinical practice.
    Quddus MB; Pratt N; Nabi G
    Urol Ann; 2019; 11(1):6-14. PubMed ID: 30787564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel clinicopathological and molecular characterization of metanephric adenoma: a study of 28 cases.
    Ding Y; Wang C; Li X; Jiang Y; Mei P; Huang W; Song G; Wang J; Ping G; Hu R; Miao C; He X; Chen G; Li H; Zhu Y; Zhang Z
    Diagn Pathol; 2018 Aug; 13(1):54. PubMed ID: 30111351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and Chromosomal Aberrations and Their Clinical Significance in Renal Neoplasms.
    Yap NY; Rajandram R; Ng KL; Pailoor J; Fadzli A; Gobe GC
    Biomed Res Int; 2015; 2015():476508. PubMed ID: 26448938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical phenotype and molecular pathological characteristics of metanephric adenoma.
    Sun Z; Kan S; Zhang L; Zhang Y; Jing H; Huang G; Yu Q; Wu J
    Int J Clin Exp Pathol; 2015; 8(6):6031-6. PubMed ID: 26261480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Composite tumor of metanephric adenoma and Wilms' tumor of the kidney: A case report and review of the literature.
    Zhu P; Yan F; Yang Z; Meng L; Ao Q
    Oncol Lett; 2013 Apr; 5(4):1311-1314. PubMed ID: 23599785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metanephric adenoma of the kidney: a clinicopathological and molecular study of two cases.
    Burger M; Junker K; Denzinger S; Schubert T; Stoehr R; Wieland WF; Hartmann A
    J Clin Pathol; 2007 Jul; 60(7):832-3. PubMed ID: 17098885
    [No Abstract]   [Full Text] [Related]  

  • 14. Metanephric adenoma of the kidney: case report and review of the literature.
    Schmelz HU; Stoschek M; Schwerer M; Danz B; Hauck EW; Weidner W; Sparwasser C
    Int Urol Nephrol; 2005; 37(2):213-7. PubMed ID: 16142545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD2-associated protein in human urogenital system and in adult kidney tumours.
    Tienari J; Lehtonen S; Lehtonen E
    Virchows Arch; 2005 Apr; 446(4):394-401. PubMed ID: 15785926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimerism of metanephric adenoma but not of carcinoma in kidney transplants.
    Mengel M; Jonigk D; Wilkens L; Radermacher J; von Wasielewski R; Lehmann U; Haller H; Mihatsch M; Kreipe H
    Am J Pathol; 2004 Dec; 165(6):2079-85. PubMed ID: 15579450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathology of renal cell carcinoma.
    Störkel S
    Urologe A; 2004 Sep; 43 Suppl 3():S118-9. PubMed ID: 15164177
    [No Abstract]   [Full Text] [Related]  

  • 18. Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype.
    Lubensky IA; Schmidt L; Zhuang Z; Weirich G; Pack S; Zambrano N; Walther MM; Choyke P; Linehan WM; Zbar B
    Am J Pathol; 1999 Aug; 155(2):517-26. PubMed ID: 10433944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous chromosome 7 and 17 gain and sex chromosome loss provide evidence that renal metanephric adenoma is related to papillary renal cell carcinoma.
    Brown JA; Anderl KL; Borell TJ; Qian J; Bostwick DG; Jenkins RB
    J Urol; 1997 Aug; 158(2):370-4. PubMed ID: 9224305
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.